| Document and Entity Information - shares | 6 Months Ended | |
| May 31, 2022 | Nov. 14, 2022 | |
| Document And Entity Information | ||
| Entity Registrant Name | PURTHANOL RESOURCES LTD. | |
| Entity Central Index Key | 0001126162 | |
| Document Type | 10-Q | |
| Document Period End Date | May 31, 2022 | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --11-30 | |
| Is Entity a Voluntary Filer? | No | |
| Is Entity's Reporting Status Current? | No | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Common Stock, Shares Outstanding | 244,038,890 | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2023 |
| Balance Sheets (Unaudited) - USD ($) | May 31, 2022 | Nov. 30, 2021 |
| NON CURRENT ASSET | ||
| Property, Plant and Equipment, Net | ||
| Total Assets | ||
| Current Liabilities | ||
| Accounts payable | 40,967 | 39,249 |
| Due to related party | 863,890 | 837,984 |
| TOTAL LIABILITIES | 904,857 | 877,233 |
| Stockholders' Equity | ||
| Preferred stock, $0.0001 par value authorized 80,000,000 shares authorized. None issued and outstanding | ||
| Common stock, $0.0001 par value authorized 260,000,000 shares authorized, 244,038,890 shares issued and outstanding | 24,403 | 24,403 |
| Additional Paid in capital (deficiency) | 3,242,350 | 3,242,350 |
| Accumulated Deficit | (4,171,610) | (4,143,986) |
| TOTAL STOCKHOLDERS' DEFICIT | (904,857) | (877,233) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
| Balance Sheets (Parenthetical) - $ / shares | May 31, 2022 | Nov. 30, 2012 |
| Statement of Financial Position [Abstract] | ||
| Preferred stock authorized shares | 80,000,000 | 80,000,000 |
| Preferred stock par value shares | $ 0.0001 | $ 0.0001 |
| Preferred stock shares issued | 0 | 0 |
| Preferred stock shares outstanding | 0 | 0 |
| Common stock authorized shares | 260,000,000 | 260,000,000 |
| Common stock par value shares | $ 0.0001 | $ 0.0001 |
| Common stock shares issued | 244,038,890 | 244,038,890 |
| Common stock shares outstanding | 244,038,890 | 244,038,890 |
| Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
| May 30, 2022 | May 30, 2021 | May 31, 2022 | May 31, 2021 | |
| Income Statement [Abstract] | ||||
| Brokerage feees | $ 507 | $ 507 | $ 1,014 | $ 1,014 |
| Administrative fees | 12,500 | 12,500 | 25,000 | 25,000 |
| Professional Fees | 704 | 1,610 | ||
| TOTAL OPERATING EXPENSES | (13,711) | (13,007) | $ (27,624) | $ (26,014) |
| NET LOSS | $ (13,711) | $ (13,007) | ||
| LOSS PER COMMON SHARE - BASIC AND DILUTED | $ 0 | $ 0 | $ 0 | $ 0 |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC AND DILUTED | 244,038,890 | 244,038,890 | 244,038,890 | 244,038,890 |
| Shareholders Equity - USD ($) | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
| Beginning Balance, Shares at Nov. 30, 2020 | 244,038,890 | |||
| Beginning Balance, Amount at Nov. 30, 2020 | $ 24,403 | $ 3,242,350 | $ (4,086,958) | $ (820,205) |
| Net loss | (13,007) | (13,007) | ||
| Ending Balance, Shares at Feb. 28, 2021 | 244,038,890 | |||
| Ending Balance, Amount at Feb. 28, 2021 | $ 24,403 | 3,242,350 | (4,099,965) | (833,212) |
| Net loss | (13,007) | (13,007) | ||
| Ending Balance, Shares at May. 31, 2021 | 244,038,890 | |||
| Ending Balance, Amount at May. 31, 2021 | $ 24,403 | 3,242,350 | (4,112,972) | (846,219) |
| Beginning Balance, Shares at Nov. 30, 2021 | 244,038,890 | |||
| Beginning Balance, Amount at Nov. 30, 2021 | $ 24,403 | 3,242,350 | (4,143,986) | (877,233) |
| Net loss | (13,913) | (13,913) | ||
| Ending Balance, Shares at Feb. 28, 2022 | 244,038,890 | |||
| Ending Balance, Amount at Feb. 28, 2022 | $ 24,403 | 3,242,350 | (4,157,899) | (891,146) |
| Net loss | (13,711) | (13,711) | ||
| Ending Balance, Shares at May. 31, 2022 | 244,038,890 | |||
| Ending Balance, Amount at May. 31, 2022 | $ 24,403 | $ 3,242,350 | $ (4,171,610) | $ (904,857) |
| Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
| May 31, 2022 | May 31, 2021 | May 31, 2022 | May 31, 2021 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | $ (13,711) | $ (13,007) | ||
| Changes in operating assets and liabilities | ||||
| Accounts payable | $ 1,718 | $ 1,014 | ||
| NET CASH USED IN OPERATING ACTIVITIES | (25,906) | (25,000) | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Advances from related party | 25,906 | 25,906 | ||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 25,906 | 25,906 | ||
| NET CHANGE IN CASH | ||||
| CASH, BEGINNING OF PERIOD | ||||
| CASH, END OF PERIOD | ||||
| NOTE 1 - BASIS OF PRESENTATION | 6 Months Ended |
| May 31, 2022 | |
| Accounting Policies [Abstract] | |
| NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES PURTHANOL RESOURCES LIMITED (formerly Global Biotech Corp.) (the Company) was incorporated in the State of Delaware on November 2, 1998, to be an Application Service provider in the E-health sector. On March 5, 2003, this business was sold, market, unsuccessfully. On February 25, 2005, it discontinued its vehicle tracking business. On August 15, 2007, the Company entered the oxygenated beverage market. The Company changed its mission and its objective was to produce Bio fuel alternatives, via the acquisition of the Purthanol process in September 2013 and the acquisition of Bio Cardel Quebec in December 2013. The Company changed its name from Global Biotech Corp. to Purthanol Resources Limited on September 30, 2013. Currently the Company has not been operating, and has not been operating, and has been inactive since 2015.There are no operations, sales, and activities as far as marketing and production. Basis of Presentation – Unaudited Financial Statements The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for financial information and with the instructions to Form 10-Q. They do not include all information and footnotes required by United States generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the fiscal year ended November 30, 2021 included in the Company’s 10-K filed with the Securities and Exchange Commission. The unaudited financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the six months ended May 31, 2022 are not necessarily indicative of the results that may be expected for the year ending November 30, 2022. Risks and Uncertainties The pandemic caused by an outbreak of a new strain of corona virus (“COVID-19”) has resulted, and is likely to continue to result, in significant national and global economic disruption and may adversely affect our business. Based on the Company’s current assessment, the Company does not expect some material impact on its long-term operation due to the worldwide spread of the COVID-19 virus. However, the Company is actively monitoring this situation and the possible effects on its financial condition, operations, suppliers, industry, and workforce. Use of Estimates and Assumptions Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Earnings (Loss) per Common Share The basic earnings (loss) per common share is calculated by dividing the Company’s net income (loss) available to common shareholders by the weighted average number of common shares during the period. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. As of May 31, 2022, there were no common stock equivalents outstanding. Income Taxes The Company follows the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying mounts of existing assets and liabilities and their respective tax balances and tax loss carryforwards’. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment. Recent Accounting Standards The Company does not expect the adoption of any recent accounting standards to have a material impact on its financial statements. Subsequent Events The Company has evaluated subsequent events through the date the financial statements were issued for disclosure purposes. No events have occurred subsequent to balance sheet date and through date of this filing that would require adjustment to or disclosure in the financial statements. |
| NOTE 2 - GOING CONCERN | 6 Months Ended |
| May 31, 2022 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| GOING CONCERN | NOTE 2 – GOING CONCERN To date the Company has generated no revenues from its business operations and has incurred operating losses since inception. As at May 31, 2022, the Company has a working capital deficit of $904,857 and has reported an accumulated deficit of $4,171,610. The Company requires additional funding to meet its ongoing obligations and to fund anticipated operating losses. The ability of the Company to continue as a going concern is dependent on raising capital to fund its initial business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern for a period of 12 months from the issue date of these financials. The Company intends to continue to fund its business by way of private placements and advances from related parties as may be required. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty. |
| NOTE 3 – RELATED PARTY TRANSACTIONS | 6 Months Ended |
| May 31, 2022 | |
| Notes to Financial Statements | |
| NOTE 3 RELATED PARTY TRANSACTIONS | NOTE 3 – RELATED PARTY TRANSACTIONS For the six months period presented in balance sheet as of May 31, 2022, the Company owes $25,906 to CEO for management fees. During six-month period ended May 31, 2021, the Company owes CEO, Leonard Stella $25,906 for management fees of $25,000 and SEC filing fees of $906. The total amount owing to the Company’s current CEO as of May 31, 2022 was $863,890 and $837,984 as of November 30, 2021. The balances due are unsecured and non-interest-bearing with no set terms of repayment. |
| NOTE 4 - EQUITY | 6 Months Ended |
| May 31, 2022 | |
| Equity [Abstract] | |
| EQUITY | NOTE 4 – EQUITY The Company has 80,000,000 preferred shares authorized with a par value of $0.0001 that are non-voting in terms of rights. The Company has 260,000,000 common shares authorized with a par value of $0.0001 per share. There are 244,038,890 common shares issued and outstanding as of May 31, 2022 which are voting in terms of rights and May 31, 2021 respectively. Common shares have been issued and paid in amount of $24,403 par value since inception. |
| NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
| May 31, 2022 | |
| Accounting Policies [Abstract] | |
| Basis of Presentation – Unaudited Financial Statements | Basis of Presentation – Unaudited Financial Statements The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for financial information and with the instructions to Form 10-Q. They do not include all information and footnotes required by United States generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the fiscal year ended November 30, 2021 included in the Company’s 10-K filed with the Securities and Exchange Commission. The unaudited financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the six months ended May 31, 2022 are not necessarily indicative of the results that may be expected for the year ending November 30, 2022. |
| Risks and Uncertainties | Risks and Uncertainties The pandemic caused by an outbreak of a new strain of corona virus (“COVID-19”) has resulted, and is likely to continue to result, in significant national and global economic disruption and may adversely affect our business. Based on the Company’s current assessment, the Company does not expect some material impact on its long-term operation due to the worldwide spread of the COVID-19 virus. However, the Company is actively monitoring this situation and the possible effects on its financial condition, operations, suppliers, industry, and workforce. |
| Use of Estimates and Assumptions | Use of Estimates and Assumptions Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. |
| Cash and Cash Equivalents | Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. |
| Earnings (Loss) per Common Share | Earnings (Loss) per Common Share The basic earnings (loss) per common share is calculated by dividing the Company’s net income (loss) available to common shareholders by the weighted average number of common shares during the period. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. As of May 31, 2022, there were no common stock equivalents outstanding. |
| Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying mounts of existing assets and liabilities and their respective tax balances and tax loss carryforwards’. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment. |
| Recent Accounting Standards | Recent Accounting Standards The Company does not expect the adoption of any recent accounting standards to have a material impact on its financial statements. |
| Subsequent Events | Subsequent Events The Company has evaluated subsequent events through the date the financial statements were issued for disclosure purposes. No events have occurred subsequent to balance sheet date and through date of this filing that would require adjustment to or disclosure in the financial statements. |
| NOTE 2 - GOING CONCERN (Details Narrative) - USD ($) | May 31, 2022 | Nov. 30, 2021 |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
| Working Capital | $ 904,857 | |
| Accumulated Deficit | $ (4,171,610) | $ (4,143,986) |
